Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
19 Aug 22
NT 10-Q
Notice of late quarterly filing
15 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10 Apr 24
8-K
Changes in Registrant's Certifying Accountant
9 Apr 24
8-K
Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX
4 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
26 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Jan 24
8-K
Entry into a Material Definitive Agreement
29 Nov 23
8-K
Third Quarter Core Operating Expenses Reduced 37% Compared to Third Quarter of 2022
8 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Oct 23
8-K
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
5 Oct 23
8-K
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
22 Sep 23
Registration and prospectus
424B4
Prospectus supplement with pricing info
3 Oct 23
S-1/A
IPO registration (amended)
27 Sep 23
S-1/A
IPO registration (amended)
11 Sep 23
S-1
IPO registration
25 Aug 23
S-8
Registration of securities for employees
23 Jun 23
424B5
Prospectus supplement for primary offering
24 Apr 23
424B4
Prospectus supplement with pricing info
8 Feb 23
S-1MEF
Registration of additional securities for an S-1
3 Feb 23
S-1/A
IPO registration (amended)
3 Feb 23
RW WD
Withdrawal of registration withdrawal request
2 Feb 23
Proxies
DEF 14A
Definitive proxy
24 Jan 24
PRE 14A
Preliminary proxy
5 Jan 24
DEF 14A
Definitive proxy
10 Nov 22
PRE 14A
Preliminary proxy
31 Oct 22
DEFA14A
Additional proxy soliciting materials
1 Sep 20
DEF 14A
Definitive proxy
10 Aug 20
DEFA14A
Additional proxy soliciting materials
13 Jun 19
DEF 14A
Definitive proxy
13 Jun 19
PRE 14A
Preliminary proxy
31 May 19
DEF 14A
Definitive proxy
30 Apr 18
Other
EFFECT
Notice of effectiveness
2 Oct 23
CORRESP
Correspondence with SEC
28 Sep 23
UPLOAD
Letter from SEC
30 Aug 23
EFFECT
Notice of effectiveness
6 Feb 23
CORRESP
Correspondence with SEC
3 Feb 23
CORRESP
Correspondence with SEC
3 Feb 23
CORRESP
Correspondence with SEC
1 Feb 23
CORRESP
Correspondence with SEC
1 Feb 23
UPLOAD
Letter from SEC
20 Jan 23
EFFECT
Notice of effectiveness
20 Sep 21
Ownership
SC 13G
Schneid Yair
17 Jan 24
3
Yair Schneid
16 Jan 24
4
THOMAS STANKOVICH
8 Nov 23
4
THOMAS STANKOVICH
19 Jul 23
4
THOMAS STANKOVICH
6 Jul 23
SC 13D
Matthew Joseph Nachtrab Revocable Trust 2014
17 Mar 23
4
THOMAS STANKOVICH
7 Mar 23
SC 13D
FOLEY & LARDNER/ FA
15 Feb 23
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 23
4
THOMAS STANKOVICH
20 Dec 22